Midas Pharma is an innovative pharmaceutical company headquartered in Ingelheim, Germany, with a focus on offering products, services, and expertise across the entire pharmaceutical value chain - from Starting Materials and Active Pharmaceutical Ingredients to market-ready Finished Products and Devices. Established in 1988, this family-owned company has steadily expanded its competencies and currently operates in 10 locations across major pharmaceutical markets globally, employing a team of more than 250 employees. The company's slogan, "Trust. Expertise. Added Value.", reflects its commitment to providing substantial support to its customers in coordinating complex pharmaceutical projects and creating significant added value. With a solid track record spanning over three decades, Midas Pharma has garnered recognition for its success in contributing to the Pharma sector. Midas Pharma operates in the Biotechnology, Manufacturing, and Pharmaceutical industries, leveraging its extensive knowledge, local contacts, and well-established networks to execute pharmaceutical projects effectively. Despite the absence of specific details regarding the last investment and investors, Midas Pharma's longstanding presence and expertise position it as a notable player in the pharmaceutical industry, offering valuable opportunities for potential partnerships and investments.
There is no investment information
No recent news or press coverage available for Midas Pharma.